IberiaBank’s Pediatrix Medical MD Stock Holding History

IberiaBank’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-6,168	Closed	-$204K	–	265
2018 Q4	$204K	Sell	6,168 -20	-0.3%	-$804	0.03%	236
2018 Q3	$289K	Buy	+6,188	New	+$284K	0.04%	229
2018 Q1	–	Sell	-7,512	Closed	-$401K	–	229
2017 Q4	$401K	Hold	7,512	–	–	0.06%	182
2017 Q3	$318K	Buy	+7,512	New	+$357K	0.05%	186

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

IberiaBank's MD Position: Q1 2019 in Review

IberiaBank sold out of Pediatrix Medical (MD) in Q1 2019, closing a stake of 6,168 shares — an estimated $204K sold.

IberiaBank first reported a position in MD in Q3 2017 and held it in 4 quarters. The position peaked at $401K in Q4 2017. 297 funds tracked by Wall St. Rank hold MD as of Q1 2019.

IberiaBank reported no remaining Pediatrix Medical position as of Q1 2019 after selling out during the quarter.
IberiaBank sold 6,168 Pediatrix Medical shares in Q1 2019, an estimated $204K.
IberiaBank first reported a position in Pediatrix Medical in Q3 2017 and held it in 4 quarters.
IberiaBank's Pediatrix Medical position peaked at $401K in Q4 2017.
297 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2019.

Based on IberiaBank's 13F filing for Q1 2019, filed 22 Apr 2019.